These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16738535)

  • 1. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise.
    Brines M; Cerami A
    Kidney Int; 2006 Jul; 70(2):246-50. PubMed ID: 16738535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors.
    Brines M
    Blood Purif; 2010; 29(2):86-92. PubMed ID: 20093809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.
    Brines M; Patel NS; Villa P; Brines C; Mennini T; De Paola M; Erbayraktar Z; Erbayraktar S; Sepodes B; Thiemermann C; Ghezzi P; Yamin M; Hand CC; Xie QW; Coleman T; Cerami A
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10925-30. PubMed ID: 18676614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.
    Brines M; Grasso G; Fiordaliso F; Sfacteria A; Ghezzi P; Fratelli M; Latini R; Xie QW; Smart J; Su-Rick CJ; Pobre E; Diaz D; Gomez D; Hand C; Coleman T; Cerami A
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14907-12. PubMed ID: 15456912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.
    Brines M; Cerami A
    J Intern Med; 2008 Nov; 264(5):405-32. PubMed ID: 19017170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model.
    Spandou E; Tsouchnikas I; Karkavelas G; Dounousi E; Simeonidou C; Guiba-Tziampiri O; Tsakiris D
    Nephrol Dial Transplant; 2006 Feb; 21(2):330-6. PubMed ID: 16221709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration.
    Broxmeyer HE
    J Exp Med; 2013 Feb; 210(2):205-8. PubMed ID: 23401569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.
    Hu L; Yang C; Zhao T; Xu M; Tang Q; Yang B; Rong R; Zhu T
    J Surg Res; 2012 Jul; 176(1):260-6. PubMed ID: 21816412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected renal actions of erythropoietin.
    Westenfelder C
    Exp Nephrol; 2002; 10(5-6):294-8. PubMed ID: 12381912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin in experimental acute renal failure.
    Sharples EJ; Yaqoob MM
    Nephron Exp Nephrol; 2006; 104(3):e83-8. PubMed ID: 16837817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin is a multifunctional tissue-protective cytokine.
    Erbayraktar S; Yilmaz O; Gökmen N; Brines M
    Curr Hematol Rep; 2003 Nov; 2(6):465-70. PubMed ID: 14561390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Protective and Reparative Role of Colony-Stimulating Factors in the Brain with Cerebral Ischemia/Reperfusion Injury.
    Patel AMR; Apaijai N; Chattipakorn N; Chattipakorn SC
    Neuroendocrinology; 2021; 111(11):1029-1065. PubMed ID: 33075777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents.
    Tanaka T; Nangaku M
    Exp Cell Res; 2012 May; 318(9):1068-73. PubMed ID: 22414872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of erythropoietin on renal ischemia and reperfusion injury.
    Ates E; Yalcin AU; Yilmaz S; Koken T; Tokyol C
    ANZ J Surg; 2005 Dec; 75(12):1100-5. PubMed ID: 16398819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the β Common Receptor the Key Molecule for the Protective Effect of Erythropoietin?
    Yang Z; Wang R; Zheng Y; Luo Y
    Aging Dis; 2023 Apr; 14(2):287-289. PubMed ID: 37008064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pleiotropic effects of erythropoietin].
    Kes P; Basić-Jukić N; Furić-Cunko V
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model.
    Yang C; Zhao T; Lin M; Zhao Z; Hu L; Jia Y; Xue Y; Xu M; Tang Q; Yang B; Rong R; Zhu T
    Exp Biol Med (Maywood); 2013 Jan; 238(1):111-9. PubMed ID: 23479770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin: a hormone with multiple functions.
    Lombardero M; Kovacs K; Scheithauer BW
    Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.